Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$605K Buy
10,500
+3,500
+50% +$201K 0.24% 101
2026
Q1
$425K Hold
7,000
0.22% 92
2025
Q4
$378K Buy
7,000
+1,700
+32% +$81.8K 0.18% 87
2025
Q3
$239K Buy
5,300
+700
+15% +$32.7K 0.13% 96
2025
Q2
$213K Hold
4,600
0.11% 97
2025
Q1
$281K Hold
4,600
0.18% 85
2024
Q4
$260K Sell
4,600
-300
-6% -$16.8K 0.15% 85
2024
Q3
$254K Hold
4,900
0.16% 86
2024
Q2
$203K Hold
4,900
0.13% 88
2024
Q1
$266K Hold
4,900
0.18% 83
2023
Q4
$251K Hold
4,900
0.21% 82
2023
Q3
$251K Buy
4,900
+1,500
+44% +$91.9K 0.21% 82
2023
Q2
$217K Buy
3,400
+300
+10% +$20.1K 0.19% 93
2023
Q1
$215K Buy
+3,100
New +$219K 0.22% 86

Other funds holding BMY

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s BMY Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) increased its Bristol-Myers Squibb (BMY) stake by 50% in Q2 2026, buying an estimated $201K and bringing the position to 10,500 shares worth $605K. The position accounts for 0.24% of the portfolio, ranked #101.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in BMY in Q1 2023 and has held it in 14 quarters since. 2,006 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 10,500 shares of Bristol-Myers Squibb worth $605K as of Q2 2026.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) bought 3,500 Bristol-Myers Squibb shares in Q2 2026, an estimated $201K.
  • Bristol-Myers Squibb made up 0.24% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #101 holding.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 14 quarters since.
  • 2,006 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.